Clinical MR Spectroscopy of Brain Metastases at 1,5T and 3T.

Sponsor

Norwegian University of Science and Technology (Other)

Overall Status

Completed

CT.gov ID

NCT00184353

Collaborator

The Royal Norwegian Ministry of Health (Other)

Enrollment

Location

Duration (Months)

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Increasing magnetic field is known to give improvements in signal-to-noise-ratio (SNR) and spectral resolution. To investigate this, spectra from different subjects were examined using two clinical MR instruments operating at 1.5T and 3T respectively.

Condition or Disease	Intervention/Treatment	Phase
Neoplasm Metastases

Study Design

Study Type:

Observational

Actual Enrollment :

19 participants

Observational Model:

Case-Control

Time Perspective:

Cross-Sectional

Official Title:

In Vivo Proton MR Spectroscopy of Brain Metastases Obtained at 1,5T and 3T.

Study Start Date :

Nov 1, 2003

Actual Primary Completion Date :

Dec 1, 2004

Actual Study Completion Date :

Jun 1, 2005

Arms and Interventions

Arm	Intervention/Treatment
brain metastases 6 patients
healthy 13 volunteers

Outcome Measures

Primary Outcome Measures

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

brain metastases

Exclusion Criteria:

children
pregnancy

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Norwegian University of Science and Technology	Trondheim		Norway	N-7489

Sponsors and Collaborators

Norwegian University of Science and Technology
The Royal Norwegian Ministry of Health

Investigators

Study Director: Steinar Lundgren, MD PhD, Cancer Clinic, St.Olavs Hospital Trondheim University Hospital
Study Chair: Ingrid S Gribbestad, PhD, Norwegian University of Science and Technology, Faculty of Medicine